ALKS vs CVS
Alkermes Plc (ALKS) versus CVS Health Corp (CVS) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Not investment advice. Open the ALKS and CVS stock pages for the full models.
Not investment advice.